| Name | Title | Contact Details |
|---|
Free team website and custom mobile app. Powerful features also include stats tracking, scheduling, chat, video & photo sharing, player & team management, monetization tools and much more. Use completely free, no credit card required. Start today and t...
W3 Lab is a full-service Digital Marketing Agency. We specialize in web development, graphic design, social media, SEO, and marketing services.
Data-driven sales and marketing. MixRank tracks your customers so you dont miss an opportunity.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Make IT Simple Cybersecurity for Today’s SMB The Perfect Cybersecurity Storm for SMBs The Challenge Lack of IT Resources More Motivated and Sophisticated